CD3

Results: 135



#Item
81Join Us On FaceBook At: facebook.com/PerformanceLincolnFord  Performance Ford Lincoln Shop 24 Hours A Day Everyday@

Join Us On FaceBook At: facebook.com/PerformanceLincolnFord Performance Ford Lincoln Shop 24 Hours A Day Everyday@

Add to Reading List

Source URL: www.sgwautomotive.com

Language: English - Date: 2012-04-11 17:38:09
82Chimeric Antigen Receptor (CAR) and T Cell Receptor (TCR) Trials Registered with OBA Total Protocols Registered with OBA = 111

Chimeric Antigen Receptor (CAR) and T Cell Receptor (TCR) Trials Registered with OBA Total Protocols Registered with OBA = 111

Add to Reading List

Source URL: osp.od.nih.gov

Language: English - Date: 2014-01-09 16:15:02
83Synthetic Biology President’s Commission for the Study of Bioethical Issues  9 July 2010

Synthetic Biology President’s Commission for the Study of Bioethical Issues  9 July 2010

Add to Reading List

Source URL: osp.od.nih.gov

Language: English - Date: 2014-01-13 09:31:58
84Design of T Cell Receptors (15 min) Antoni Ribas, M.D., Ph.D. Professor of Medicine Professor of Surgery

Design of T Cell Receptors (15 min) Antoni Ribas, M.D., Ph.D. Professor of Medicine Professor of Surgery

Add to Reading List

Source URL: osp.od.nih.gov

Language: English - Date: 2014-01-13 09:43:38
85Design of T Cell Receptors (15 min) Antoni Ribas, M.D., Ph.D. Professor of Medicine Professor of Surgery

Design of T Cell Receptors (15 min) Antoni Ribas, M.D., Ph.D. Professor of Medicine Professor of Surgery

Add to Reading List

Source URL: osp.od.nih.gov

Language: English - Date: 2014-01-09 16:16:55
86Chimeric Antigen Receptor (CAR) and T Cell Receptor (TCR) Trials Registered with OBA Total Protocols Registered with OBA = 111

Chimeric Antigen Receptor (CAR) and T Cell Receptor (TCR) Trials Registered with OBA Total Protocols Registered with OBA = 111

Add to Reading List

Source URL: osp.od.nih.gov

Language: English - Date: 2014-01-13 09:29:04
87T Cell ImmunotherapyOptimizing Trial Design Session I Current Status of Cancer Immunotherapy: Trials, Results, and Challenges Investigator: Helen Heslop Institution: Baylor College of Medicine

T Cell ImmunotherapyOptimizing Trial Design Session I Current Status of Cancer Immunotherapy: Trials, Results, and Challenges Investigator: Helen Heslop Institution: Baylor College of Medicine

Add to Reading List

Source URL: osp.od.nih.gov

Language: English - Date: 2014-01-09 16:15:27
88T Cell ImmunotherapyOptimizing Trial Design Session I Current Status of Cancer Immunotherapy: Trials, Results, and Challenges Investigator: Helen Heslop Institution: Baylor College of Medicine

T Cell ImmunotherapyOptimizing Trial Design Session I Current Status of Cancer Immunotherapy: Trials, Results, and Challenges Investigator: Helen Heslop Institution: Baylor College of Medicine

Add to Reading List

Source URL: osp.od.nih.gov

Language: English - Date: 2014-01-13 09:31:49
89Synthetic Biology President’s Commission for the Study of Bioethical Issues  9 July 2010

Synthetic Biology President’s Commission for the Study of Bioethical Issues  9 July 2010

Add to Reading List

Source URL: osp.od.nih.gov

Language: English - Date: 2014-01-09 16:15:33
9014V[removed]pages) By Recall Management Division at 12:50 pm, Mar 11, [removed]

14V[removed]pages) By Recall Management Division at 12:50 pm, Mar 11, [removed]

Add to Reading List

Source URL: www-odi.nhtsa.dot.gov

Language: English